When we think about genes, we often imagine a straightforward process where DNA is copied into RNA, and RNA is used to make proteins. But in reality, our cells have a set of clever editing tricks that can create many different messages from the same gene, and these tricks dramatically influence how our bodies function.

Two of the most important tricks are alternative polyadenylation (APA) and alternative splicing (AS).

• APA changes where the RNA molecule ends, which can affect how long it lasts in the cell, where it travels, and how efficiently it’s used to make protein.
• AS works by mixing and matching different sections of the RNA, producing multiple protein variants from a single gene.

Both processes are essential for normal biology, but they can also go wrong in diseases such as cancer or neurodegenerative disorders.

Different forms of eukaryotic APA and AS events

a The two types of APA, that is, IPA and UTR-APA, and their impact on the functional proteome. PAS, polyadenylation site; RBP, RNA-binding protein; TSS, transcription start site. b A schematic representation of the seven major types of AS.

Thanks to high-throughput RNA sequencing, scientists can now study APA and AS on a large scale. This has led to powerful computational tools that detect and measure these events across different cell types and conditions. Some methods focus on bulk RNA sequencing (looking at many cells at once), while others are designed for single-cell RNA sequencing, revealing how individual cells fine-tune their gene expression.

Researchers from the University of Central Florida explored the latest strategies for identifying and analyzing APA and AS. They discuss the strengths and weaknesses of different computational methods, highlight their applications in both healthy and diseased states, and look at how these tools are being adapted for the unique challenges of single-cell data.

By understanding how these RNA processing steps are controlled, researchers are uncovering new insights into gene regulation, insights that could lead to better diagnostics, targeted therapies, and a deeper understanding of human biology.